• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于问卷的原发性局限性多汗症的流行病学调查和日本原发性腋窝多汗症的当前医学治疗管理调查。

Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan.

机构信息

Ikebukuro Nishiguchi Fukurou Dermatology Clinic, 1-39-4 Nishi-Ikebukuro, Toshima-ku, Tokyo, Japan.

Maruho Co., Ltd., 1-5-22 Nakatsu, Kita-ku, Osaka, Japan.

出版信息

Arch Dermatol Res. 2023 Apr;315(3):409-417. doi: 10.1007/s00403-022-02365-9. Epub 2022 Jun 29.

DOI:10.1007/s00403-022-02365-9
PMID:35768620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10020310/
Abstract

To obtain current epidemiological information on primary focal hyperhidrosis in Japan, a large epidemiological survey was conducted using a web-based questionnaire. The prevalence of primary focal hyperhidrosis was 10.0% and the site-specific prevalence was highest for primary axillary hyperhidrosis (5.9%). The proportion of respondents with primary focal hyperhidrosis who had consulted a physician was 4.6%, which was similar to the low prevalence reported previously in 2013 in Japan. A questionnaire survey for physicians and individuals with primary axillary hyperhidrosis on the current medical management of primary axillary hyperhidrosis showed that physicians recognized the existence of patients who were very worried about hyperhidrosis, but failed to provide active treatment. Regarding the information provided by patients to physicians at presentation, it was found that patients failed to provide sufficient information to the physicians about their worries in daily life. Among individuals who had sought medical care with primary axillary hyperhidrosis, 62.3% reported that they were not currently receiving treatment, highlighting a challenge to be addressed regarding continued treatment. Frequently chosen options leading to willingness to receive treatment were less expensive treatment and highly effective treatment as well as feeling free to consult a physician, suggesting a desire for an improved medical environment.

摘要

为了获取日本原发性局限性多汗症的最新流行病学信息,我们采用网络问卷对其进行了大规模的流行病学调查。原发性局限性多汗症的患病率为 10.0%,以原发性腋窝多汗症的部位特异性患病率最高(5.9%)。曾就诊于医生的原发性局限性多汗症患者比例为 4.6%,与日本 2013 年之前报道的低患病率相似。对原发性腋窝多汗症的医生和患者进行的原发性腋窝多汗症当前医学治疗管理的问卷调查显示,医生认识到存在对多汗症非常担忧的患者,但未能提供积极的治疗。关于患者就诊时向医生提供的信息,发现患者未能向医生充分说明其日常生活中的担忧。在因原发性腋窝多汗症而寻求医疗的人群中,62.3%的人表示他们目前未接受治疗,这突显了持续治疗所面临的挑战。愿意接受治疗的常见选择包括费用更低的治疗和更有效的治疗,以及能够自由咨询医生,这表明患者希望改善医疗环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/d3a97c03707e/403_2022_2365_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/b50c113a761e/403_2022_2365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/a7505c7278f3/403_2022_2365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/90a15a98517e/403_2022_2365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/a3ec3b33218e/403_2022_2365_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/d3a97c03707e/403_2022_2365_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/b50c113a761e/403_2022_2365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/a7505c7278f3/403_2022_2365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/90a15a98517e/403_2022_2365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/a3ec3b33218e/403_2022_2365_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7bb/10020310/d3a97c03707e/403_2022_2365_Fig5_HTML.jpg

相似文献

1
Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan.基于问卷的原发性局限性多汗症的流行病学调查和日本原发性腋窝多汗症的当前医学治疗管理调查。
Arch Dermatol Res. 2023 Apr;315(3):409-417. doi: 10.1007/s00403-022-02365-9. Epub 2022 Jun 29.
2
Cost-of-illness study for axillary hyperhidrosis in Japan.日本腋窝多汗症的疾病经济研究。
J Dermatol. 2021 Oct;48(10):1482-1490. doi: 10.1111/1346-8138.16050. Epub 2021 Jul 9.
3
Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis.日本原发性局灶性多汗症的流行病学研究与思考:基于问卷调查分析
J Dermatol. 2013 Nov;40(11):886-90. doi: 10.1111/1346-8138.12258. Epub 2013 Sep 23.
4
Treatment of Axillary hyperhidrosis.腋窝多汗症的治疗。
J Cosmet Dermatol. 2022 Jan;21(1):62-70. doi: 10.1111/jocd.14378. Epub 2021 Aug 20.
5
US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.美国多汗症患病率及其对腋窝多汗症患者的影响:一项全国性调查结果
J Am Acad Dermatol. 2004 Aug;51(2):241-8. doi: 10.1016/j.jaad.2003.12.040.
6
Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.二极管激光脱毛不干扰肉毒杆菌毒素A治疗腋窝多汗症。
Lasers Surg Med. 2010 Mar;42(3):211-4. doi: 10.1002/lsm.20891.
7
Treatment of focal hyperhidrosis.局灶性多汗症的治疗。
J Cutan Med Surg. 2007 Mar-Apr;11(2):67-77. doi: 10.2310/7750.2007.00012.
8
Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients.了解多汗症患者的体验:对1985名患者的全国性调查。
J Drugs Dermatol. 2018 Apr 1;17(4):392-396.
9
Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro.里约热内卢医学生原发性多汗症的患病率和特征。
PLoS One. 2019 Sep 13;14(9):e0220664. doi: 10.1371/journal.pone.0220664. eCollection 2019.
10
Primary Axillary Hyperhidrosis Treatment Using High Intensity Focused Fractional Radiofrequency Microneedling.使用高强度聚焦微针射频治疗原发性腋窝多汗症
J Drugs Dermatol. 2018 Jul 1;17(7):745-748.

引用本文的文献

1
Seasonal Variation and Meteorological Correlates of Botulinum Toxin Injections for Axillary Hyperhidrosis in Japan: A Retrospective Analysis.日本腋窝多汗症肉毒杆菌毒素注射的季节变化及气象相关因素:一项回顾性分析
Cureus. 2025 May 12;17(5):e83996. doi: 10.7759/cureus.83996. eCollection 2025 May.
2
Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A-Observational Study.Botulinum Toxin A in the Treatment of Primary Axillary Hyperhidrosis: A Double-Dose Cohort Study.
Toxins (Basel). 2024 Jul 16;16(7):320. doi: 10.3390/toxins16070320.
3
The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms.

本文引用的文献

1
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.腋下出汗日常日记的开发与验证:一种用于评估腋下出汗严重程度的患者报告结局指标。
J Patient Rep Outcomes. 2019 Sep 5;3(1):59. doi: 10.1186/s41687-019-0148-8.
2
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.标题:托吡酯硫酸盐局部治疗原发性腋窝多汗症:来自 ATMOS-1 和 ATMOS-2 三期随机对照试验的患者报告结局。
Am J Clin Dermatol. 2019 Feb;20(1):135-145. doi: 10.1007/s40257-018-0395-0.
3
一种专门针对原发性局限性多汗症症状所开发的焦虑量表的信度和效度。
Biopsychosoc Med. 2024 Jun 4;18(1):14. doi: 10.1186/s13030-024-00310-y.
The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content.
多汗症疾病严重程度测量——腋窝:项目内容的概念化与开发
J Drugs Dermatol. 2018 Jul 1;17(7):707-714.
4
The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation.多汗症对患者日常生活及生活质量的影响:一项定性研究。
Health Qual Life Outcomes. 2017 Jun 8;15(1):121. doi: 10.1186/s12955-017-0693-x.
5
Hyperhidrosis: an update on prevalence and severity in the United States.多汗症:美国患病率及严重程度的最新情况
Arch Dermatol Res. 2016 Dec;308(10):743-749. doi: 10.1007/s00403-016-1697-9. Epub 2016 Oct 15.
6
Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population.瑞典多汗症的患病率及特征:一项针对普通人群的横断面研究
Dermatology. 2016;232(5):586-591. doi: 10.1159/000448032. Epub 2016 Sep 1.
7
The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH).患有或不患有多汗症 (HH) 的患者中焦虑和抑郁的患病率。
J Am Acad Dermatol. 2016 Dec;75(6):1126-1133. doi: 10.1016/j.jaad.2016.07.001. Epub 2016 Aug 25.
8
Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver.上海和温哥华皮肤科门诊患者多汗症的患病率及人口统计学特征
PLoS One. 2016 Apr 22;11(4):e0153719. doi: 10.1371/journal.pone.0153719. eCollection 2016.
9
The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).多汗症特定疾病生活质量量表的开发与验证:多汗症生活质量指数(HidroQOL©)
Qual Life Res. 2015 Apr;24(4):1017-27. doi: 10.1007/s11136-014-0825-2. Epub 2014 Nov 1.
10
Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis.日本原发性局灶性多汗症的流行病学研究与思考:基于问卷调查分析
J Dermatol. 2013 Nov;40(11):886-90. doi: 10.1111/1346-8138.12258. Epub 2013 Sep 23.